ChronoLiver: Circadian Clock Disruption Tracker
hepatic circadian clock disruption and pathologies
| Competitors | Pros | Cons | Starting price | Product similarity | Customer feedback |
|---|---|---|---|---|---|
Market leader in CGM High accuracy Strong patient adoption | Focused primarily on glucose monitoring Limited to diabetes market | $99.00 | 90% similar Dexcom's CGM systems track glucose levels continuously, and since hepatic glucose metabolism is tightly regulated by the circadian clock, disruptions in liver circadian rhythms directly manifest in glucose dysregulation — making CGM data a relevant proxy for hepatic clock disruption. Both products target metabolic health monitoring with real-time physiological data. | <UNKNOWN> | |
Revolutionary technology Comprehensive biomarker monitoring Strong funding backing | Early stage company Not yet FDA approved Limited market presence | — | 90% similar Nutromics' Lab-on-a-Patch monitors hundreds of biomarkers in real-time, which overlaps with ChronoLiver's need to track circadian-regulated hepatic biomarkers (e.g., liver enzymes, metabolites) continuously. Both target clinical researchers and healthcare providers seeking continuous, non-invasive biological monitoring beyond standard snapshots. | Not yet rated | |
Best in class accuracy for MASH detection and stratification Outperforms elastography with lower failure rates, especially in high BMI patients Strong correlation with biopsy features (NAS and fibrosis) | Requires MRI access and expertise Higher upfront cost compared to basic blood tests Limited to facilities with compatible MRI equipment | — | 85% similar Perspectum's LiverMultiScan directly assesses liver health and pathologies such as MASLD/MASH using quantitative imaging, which overlaps with ChronoLiver's focus on hepatic pathologies linked to circadian clock disruption. Both serve clinicians and patients dealing with chronic liver disease and aim to provide objective, non-invasive liver assessment. | 4.2/5 | |
Strong in diabetes monitoring FDA-approved devices Healthcare provider trust | Primarily focused on specific conditions Limited broader health monitoring | $35.00 | 80% similar Abbott's continuous glucose monitoring devices track metabolic parameters relevant to liver function and circadian-regulated glucose homeostasis, overlapping with ChronoLiver's focus on hepatic circadian disruption and its metabolic consequences. Both target chronic disease management with continuous physiological data streams. | UNKNOWN | |
Large market presence and brand recognition Advanced AI integration capabilities Comprehensive health monitoring ecosystem | Premium pricing may limit accessibility Ecosystem lock-in requirements Battery life limitations for continuous monitoring | $249.00 | 80% similar Apple Watch's health monitoring features — including sleep tracking and activity data — capture behavioral and physiological signals that reflect circadian rhythm alignment, which is central to ChronoLiver's focus on circadian clock disruption. Both products target health-conscious individuals seeking continuous, wearable health insights. | 4.5/5 | |
Large consumer base Seamless ecosystem integration Advanced sensors | Consumer-focused rather than clinical Limited medical device approvals Ecosystem lock-in | $249.00 | 80% similar Apple's Watch and Health ecosystem collects longitudinal data on sleep, activity, and heart rate — all circadian-relevant signals — that could inform circadian rhythm disruption patterns similar to what ChronoLiver aims to track. Both leverage continuous wearable monitoring to surface health insights for individuals with chronic health concerns. | 4.5/5 | |
Early detection of health risks Better self-management capabilities High user adoption and engagement | Limited clinical-grade accuracy Primarily consumer-focused rather than medical-grade | $249.00 | 80% similar Apple's wearable fitness and health tracking devices monitor sleep and activity patterns that are key indicators of circadian rhythm disruption, a core concern of ChronoLiver. Both solutions use continuous wearable data to support remote health monitoring in individuals at risk for chronic conditions. | <UNKNOWN> | |
Real-time intervention capabilities Better glucose level management Increased patient safety | Limited to diabetes management Requires ongoing sensor replacements | $89.00 | 80% similar Dexcom's smartphone-integrated CGM systems provide continuous tracking of glucose — a hepatic circadian clock-regulated metabolite — making their data directly relevant to identifying hepatic circadian disruption patterns. Both products integrate digital health tools to monitor metabolic health in real time for chronic disease management. | <UNKNOWN> | |
Multi-signal monitoring capabilities Comprehensive physiological data Advanced sensor integration | Potentially higher complexity May require specialized expertise | — | 80% similar Fibion Helix's multi-signal monitoring of HRV and accelerometry is used specifically for studying circadian rhythms and physiological responses, directly overlapping with ChronoLiver's focus on circadian clock disruption. Both target researchers and clinicians investigating circadian biology and its downstream health effects. | 4.2/5 | |
Multi-sensor technology Specialized in circadian rhythm research Comprehensive product portfolio | Smaller market presence compared to established competitors | — | 80% similar Fibion Krono is a dedicated circadian rhythm and sleep monitoring device targeting researchers and clinicians — the same scientific community ChronoLiver serves in studying hepatic circadian clock disruption. Both products focus specifically on measuring circadian rhythm parameters to support research into clock-related pathologies. | 4.2/5 |
View Files per page
1-10 of 20 competitors
Pros
Market leader in CGM
High accuracy
Strong patient adoption
Cons
Focused primarily on glucose monitoring
Limited to diabetes market
Starting price: $99.00
Product similarity: 90% Dexcom's CGM systems track glucose levels continuously, and since hepatic glucose metabolism is tightly regulated by the circadian clock, disruptions in liver circadian rhythms directly manifest in glucose dysregulation — making CGM data a relevant proxy for hepatic clock disruption. Both products target metabolic health monitoring with real-time physiological data.
Customer feedback: <UNKNOWN>
Pros
Revolutionary technology
Comprehensive biomarker monitoring
Strong funding backing
Cons
Early stage company
Not yet FDA approved
Limited market presence
Starting price: —
Product similarity: 90% Nutromics' Lab-on-a-Patch monitors hundreds of biomarkers in real-time, which overlaps with ChronoLiver's need to track circadian-regulated hepatic biomarkers (e.g., liver enzymes, metabolites) continuously. Both target clinical researchers and healthcare providers seeking continuous, non-invasive biological monitoring beyond standard snapshots.
Customer feedback: Not yet rated
Pros
Best in class accuracy for MASH detection and stratification
Outperforms elastography with lower failure rates, especially in high BMI patients
Strong correlation with biopsy features (NAS and fibrosis)
Cons
Requires MRI access and expertise
Higher upfront cost compared to basic blood tests
Limited to facilities with compatible MRI equipment
Starting price: —
Product similarity: 85% Perspectum's LiverMultiScan directly assesses liver health and pathologies such as MASLD/MASH using quantitative imaging, which overlaps with ChronoLiver's focus on hepatic pathologies linked to circadian clock disruption. Both serve clinicians and patients dealing with chronic liver disease and aim to provide objective, non-invasive liver assessment.
Customer feedback: 4.2/5
Pros
Strong in diabetes monitoring
FDA-approved devices
Healthcare provider trust
Cons
Primarily focused on specific conditions
Limited broader health monitoring
Starting price: $35.00
Product similarity: 80% Abbott's continuous glucose monitoring devices track metabolic parameters relevant to liver function and circadian-regulated glucose homeostasis, overlapping with ChronoLiver's focus on hepatic circadian disruption and its metabolic consequences. Both target chronic disease management with continuous physiological data streams.
Customer feedback: UNKNOWN
Pros
Large market presence and brand recognition
Advanced AI integration capabilities
Comprehensive health monitoring ecosystem
Cons
Premium pricing may limit accessibility
Ecosystem lock-in requirements
Battery life limitations for continuous monitoring
Starting price: $249.00
Product similarity: 80% Apple Watch's health monitoring features — including sleep tracking and activity data — capture behavioral and physiological signals that reflect circadian rhythm alignment, which is central to ChronoLiver's focus on circadian clock disruption. Both products target health-conscious individuals seeking continuous, wearable health insights.
Customer feedback: 4.5/5
Pros
Large consumer base
Seamless ecosystem integration
Advanced sensors
Cons
Consumer-focused rather than clinical
Limited medical device approvals
Ecosystem lock-in
Starting price: $249.00
Product similarity: 80% Apple's Watch and Health ecosystem collects longitudinal data on sleep, activity, and heart rate — all circadian-relevant signals — that could inform circadian rhythm disruption patterns similar to what ChronoLiver aims to track. Both leverage continuous wearable monitoring to surface health insights for individuals with chronic health concerns.
Customer feedback: 4.5/5
Pros
Early detection of health risks
Better self-management capabilities
High user adoption and engagement
Cons
Limited clinical-grade accuracy
Primarily consumer-focused rather than medical-grade
Starting price: $249.00
Product similarity: 80% Apple's wearable fitness and health tracking devices monitor sleep and activity patterns that are key indicators of circadian rhythm disruption, a core concern of ChronoLiver. Both solutions use continuous wearable data to support remote health monitoring in individuals at risk for chronic conditions.
Customer feedback: <UNKNOWN>
Pros
Real-time intervention capabilities
Better glucose level management
Increased patient safety
Cons
Limited to diabetes management
Requires ongoing sensor replacements
Starting price: $89.00
Product similarity: 80% Dexcom's smartphone-integrated CGM systems provide continuous tracking of glucose — a hepatic circadian clock-regulated metabolite — making their data directly relevant to identifying hepatic circadian disruption patterns. Both products integrate digital health tools to monitor metabolic health in real time for chronic disease management.
Customer feedback: <UNKNOWN>
Pros
Multi-signal monitoring capabilities
Comprehensive physiological data
Advanced sensor integration
Cons
Potentially higher complexity
May require specialized expertise
Starting price: —
Product similarity: 80% Fibion Helix's multi-signal monitoring of HRV and accelerometry is used specifically for studying circadian rhythms and physiological responses, directly overlapping with ChronoLiver's focus on circadian clock disruption. Both target researchers and clinicians investigating circadian biology and its downstream health effects.
Customer feedback: 4.2/5
Pros
Multi-sensor technology
Specialized in circadian rhythm research
Comprehensive product portfolio
Cons
Smaller market presence compared to established competitors
Starting price: —
Product similarity: 80% Fibion Krono is a dedicated circadian rhythm and sleep monitoring device targeting researchers and clinicians — the same scientific community ChronoLiver serves in studying hepatic circadian clock disruption. Both products focus specifically on measuring circadian rhythm parameters to support research into clock-related pathologies.
Customer feedback: 4.2/5
1-10 of 20 competitors